Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
Beste YurdacanUnal EgeliGamze Guney EskilerIsil Ezgi EryilmazGulsah CecenerBerrin TuncaPublished in: The Journal of pharmacy and pharmacology (2019)
Consequently, SOR and UA combination could be a new therapeutic strategy for HCC treatment.
Keyphrases